#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16560	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2525	807.1	0	.	n	.	0	A69G	SNP	69	69	A	462	462	G	1039	G,A	745,289	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16560	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2525	807.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1843	1843	T	1082	T,G,C,A	1076,3,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16560	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2525	807.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1577	1577	C	1045	C,G	1044,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16560	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2525	807.1	0	HET	.	.	.	T454TG	.	454	454	T	847	847	T	1060	TG,T	778,261	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28848	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4086	881.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1943	1943	A	1126	A,T	1124,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28848	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4086	881.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2577	2577	C	957	C,T,A	954,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28848	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4086	881.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2651	2651	A	940	A	940	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28848	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4086	881.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3203	3203	C	1038	C,A	1037,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2512	folP	852	852	99.88	folP.l15.c4.ctg.1	2001	156.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	980	982	AAA	243;243;243	A;A,C,T;A	242;240,1,1;242	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2512	folP	852	852	99.88	folP.l15.c4.ctg.1	2001	156.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1211	1213	AGC	258;258;258	A,G;G;C	257,1;258;258	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5566	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3983	174.5	1	SNP	p	S91F	0	.	.	271	273	TCC	865	867	TCC	211;213;212	T,G;C,G;C	210,1;212,1;212	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5566	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3983	174.5	1	SNP	p	D95G	0	.	.	283	285	GAC	877	879	GAC	213;213;213	G;A;C	213;213;213	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5566	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3983	174.5	1	SNP	p	D95N	0	.	.	283	285	GAC	877	879	GAC	213;213;213	G;A;C	213;213;213	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2214	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1844	150.0	1	SNP	p	G45D	0	.	.	133	135	GGC	714	716	GGC	276;275;274	G;G;C	276;275;274	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1172	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1489	97.8	0	.	n	.	0	A197.	DEL	197	197	A	906	906	A	220	A	220	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5292	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3528	187.3	1	SNP	p	D86N	0	.	.	256	258	GAC	873	875	GAC	231;227;226	G;A,G,C;C,G	231;223,3,1;225,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5292	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3528	187.3	1	SNP	p	S87I	0	.	.	259	261	AGT	876	878	AGT	227;226;226	A,C;G;T,G,A	226,1;226;224,1,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5292	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3528	187.3	1	SNP	p	S87W	0	.	.	259	261	AGT	876	878	AGT	227;226;226	A,C;G;T,G,A	226,1;226;224,1,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5292	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3528	187.3	1	SNP	p	S87R	0	.	.	259	261	AGT	876	878	AGT	227;226;226	A,C;G;T,G,A	226,1;226;224,1,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5292	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3528	187.3	1	SNP	p	S88P	0	.	.	262	264	TCC	879	881	TCC	225;224;225	T;C,T;C,G	225;223,1;224,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4898	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3304	185.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1835	1837	GGC	283;280;278	G;G;C	283;280;278	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1469	1471	GCA	259;259;260	G,T,C;C,T;A	257,1,1;258,1;260	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1472	1474	ATC	261;261;258	A;T,C;C	261;260,1;258	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1484	1486	GTG	260;263;258	G;T,C;G	260;262,1;258	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1484	1486	GTG	260;263;258	G;T,C;G	260;262,1;258	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1988	1990	ACC	273;272;271	A;C;C	273;272;271	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2042	2044	GCG	252;254;255	G;C;G	252;254;255	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2042	2044	GCG	252;254;255	G;C;G	252;254;255	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2165	2167	GGC	285;283;284	G,A;G,T;C,T,G	284,1;281,2;282,1,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2174	2176	GGC	286;286;286	G;G;C	286;286;286	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2756	211.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2192	2194	CTG	283;283;281	C;T,C;G,T	283;282,1;280,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6422	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3577	224.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1871	1873	CCG	277;279;276	C;C,A;G	277;278,1;276	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2808	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2358	148.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	878	878	C	226	C	226	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	342	porB1a	984	100	94.0	porB1a.l15.c4.ctg.3	747	22.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	698	700	ACG	69;69;64	A;C;G	69;69;64	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	342	porB1a	984	100	94.0	porB1a.l15.c4.ctg.3	747	22.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	740	742	CAA	23;23;22	C;A;A	23;23;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	342	porB1a	984	174	93.1	porB1a.l15.c4.ctg.5	174	52.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	32	34	TTA	34;40;41	T;T;A	34;40;41	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	342	porB1a	984	174	93.1	porB1a.l15.c4.ctg.5	174	52.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	77	79	CAT	73;73;73	C;A;T	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	342	porB1a	984	174	93.1	porB1a.l15.c4.ctg.5	174	52.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	80	82	AGT	73;73;73	A;G;T	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	342	porB1a	984	174	93.1	porB1a.l15.c4.ctg.5	174	52.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	89	91	TAC	73;73;73	T;A,G;C	73;72,1;73	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	658	660	GAA	322;318;318	G;A;A	322;318;318	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	946	948	GAT	324;328;329	G,A;A,G;T	323,1;327,1;329	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1069	1071	TCA	307;305;300	T,G;C,G;A	306,1;304,1;300	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1198	1200	GTC	288;288;284	G;T,A;C	288;287,1;284	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1210	1212	TCT	284;286;289	T;C;T	284;286;289	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1528	1530	GCA	282;283;282	G;C;A	282;283;282	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	1	SNP	p	G120K	1	.	.	358	360	AAG	904	906	AAG	316;315;318	A;A,C;G	316;314,1;318	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	1	SNP	p	A121D	1	.	.	361	363	GAC	907	909	GAC	322;325;326	G,C;A;C	321,1;325;326	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3574	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2055	216.9	1	SNP	p	D121N	0	.	.	361	363	GAC	907	909	GAC	322;325;326	G,C;A;C	321,1;325;326	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11574	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5518	262.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2316	2318	AAT	301;297;299	A,C,G;A,G;T,A	299,1,1;296,1;298,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1738	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1483	146.3	1	SNP	p	V57M	1	.	.	169	171	ATG	703	705	ATG	306;306;308	A;T,A;G,T	306;305,1;306,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
